Fatty Acid Quality and Overweight (FO-study)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Stine Marie Ulven, Akershus University College
ClinicalTrials.gov Identifier:
NCT01034436
First received: December 16, 2009
Last updated: November 21, 2011
Last verified: November 2011
  Purpose

The purpose of this study is to study the health effects of fatty acid quality in healthy, overweight individuals.


Condition Intervention
Weight Reduction and Insulin Sensitivity
Dietary Supplement: fatty acid quality and overweight

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Basic Science
Official Title: Fatty Acid Quality and Overweight

Resource links provided by NLM:


Further study details as provided by Akershus University College:

Primary Outcome Measures:
  • Will intake of fat as diacylglycerols give weight reduction in overweight individuals? [ Time Frame: baseline (0 weeks), 12 weeks ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Will a high intake of ALA involve reduced levels of inflammatory markers? [ Time Frame: baseline (0 weeks), 12 weeks ] [ Designated as safety issue: No ]
  • Will a high intake of ALA involve changes in insulin sensitivity? [ Time Frame: baseline (0 weeks), 12 weeks ] [ Designated as safety issue: No ]

Enrollment: 41
Study Start Date: February 2009
Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Placebo Comparator: Low intake of ALA and triacylglycerols
Sunflower oil
Dietary Supplement: fatty acid quality and overweight
Duration 12 weeks
Experimental: high intake of ALA and triacylglyceroles
Canola and linseed oils
Dietary Supplement: fatty acid quality and overweight
Duration 12 weeks
Experimental: high intake of ALA and diacylglycerols
Canola and linseed oils
Dietary Supplement: fatty acid quality and overweight
Duration 12 weeks

  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • no use of medication, healthy, 27<BMI<40

Exclusion Criteria:

  • pregnant and lactating women, chronic diseases.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01034436

Locations
Norway
Akershus University College
Oslo, Lillestrom, Norway, 2001
Sponsors and Collaborators
Akershus University College
Investigators
Study Chair: Stine Marie Ulven, PhD Akershus University College
  More Information

No publications provided

Responsible Party: Stine Marie Ulven, Associate professor, Akershus University College
ClinicalTrials.gov Identifier: NCT01034436     History of Changes
Other Study ID Numbers: 6.2008.1368
Study First Received: December 16, 2009
Last Updated: November 21, 2011
Health Authority: Norway:Regional Committees for Medical and Health Research Ethics

Additional relevant MeSH terms:
Weight Loss
Overweight
Insulin Resistance
Body Weight Changes
Body Weight
Signs and Symptoms
Hyperinsulinism
Glucose Metabolism Disorders
Metabolic Diseases

ClinicalTrials.gov processed this record on July 23, 2014